Robust feature selection to predict tumor treatment outcome
Hongmei Mi1, Caroline Petitjean1, Bernard Dubray2
1QUANTification en Imagerie Fonctionnelle - Laboratoire d'Informatique, du Traitement de l'Information et des Systèmes (EA4108 - FR CNRS 3638), University of Rouen, 22, Boulevard GAMBETTA, 76183 Rouen, France.
Artificial Intelligence in Medicine
|August 26, 2015
Summary
Predicting cancer treatment outcomes is crucial for patient care. A new hierarchical forward selection (HFS) algorithm effectively identifies key clinical and PET imaging features, improving prediction accuracy and robustness.
Area of Science:
- Oncology
- Medical Imaging
- Machine Learning
Background:
- Cancer recurrence post-treatment significantly elevates mortality risk.
- Accurate prediction of treatment outcomes aids in personalized treatment planning and patient management.
- Clinical and Positron Emission Tomography (PET) imaging features are vital for prognostic assessments.
Purpose of the Study:
- To develop and evaluate a novel feature selection algorithm for identifying predictive clinical and PET-based features.
- To enhance the prediction of patient treatment outcomes and improve clinical decision-making.
- To address the challenge of small sample sizes in medical datasets through an advanced feature selection approach.
Main Methods:
- Proposed a hierarchical forward selection (HFS) algorithm for feature subset searching in a hierarchical space.
- Utilized Support Vector Machine (SVM) for evaluating feature subset prediction performance.
- Incorporated prior knowledge of Standardized Uptake Value (SUV) features into the HFS algorithm (pHFS) to enhance robustness and reduce computational cost.
Main Results:
- The HFS algorithm achieved high prediction accuracy (100% and 94%) and robustness (89% and 96%) on two real-world cancer patient datasets.
- The prior-knowledge-based HFS (pHFS) further improved robustness to 100% and 98% without compromising accuracy.
- Evaluated using leave-one-out cross-validation, incorporating clinical and PET-derived features including SUV parameters and texture features.
Conclusions:
- The proposed HFS and pHFS methods demonstrate superior performance compared to existing feature selection techniques.
- Empirical evidence shows that integrating prior knowledge into HFS enhances robustness and speeds up convergence.
- These findings suggest HFS and pHFS are promising tools for selecting informative features to predict cancer patient outcomes.
Related Concept Videos
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K


